Michigan Institute for Clinical and Health Research (MICHR) (UL1)

密歇根大学临床与转化科学奖(UM CTSA)将集中于令人敬畏的 世界上最好的研究机构之一在支持和促进临床和 翻译的“团队科学”。UM CTSA将设在新成立的密歇根大学 临床与健康研究(MICHR)。MICHR是由大学创建的，目的是最大限度地发挥 一所非常支持跨学科研究的机构，在 健康科学。MICHR在大学相关单位、国家卫生研究院、外部 行业合作伙伴和社区。绝大多数密歇根大学的学校、学院和研究所 包括一流的商业、牙科、医学、护理、社会工作、 和公共卫生，工程学院，药学学院，文学，科学和艺术学院， 运动学、社会研究所和生命科学研究所。大学拥有的健康 系统，包括综合门诊和住院设施，正在为强大的 与UM CTSA合作。MICHR主任是UM CTSA赠款的PI，并向 大学执行副校长，他还负责监督医学院和卫生系统。此外 对于赠款资源，该机构将提供近1100万美元/VR的实物支持、成本分担、 对试点和招募计划的支持，以及翻新费用，超过了NIH资金的1：1。蓝色 密歇根的十字蓝盾公司和辉瑞公司也在进行可观的投资。各部门也在 在潜在的教职员工工作中贡献超过100 FTE，以便MICHR能够为先导研究提供努力，K- 12、新的“小K计划”。这些聚合资源用于创建强大的基础设施和 基于强大的现有单位和项目以及关键临床和专业领域的学术项目提供支持 翻译学科，提供教师领导、专业知识和咨询以及高质量 服务。这些课程包括生物医学信息学、生物统计学、临床翻译、新方法、 技术核心、社区参与、道德、健康差距、儿科和监管支持。 还描述了一个从根本上重新配置的参与者和临床交互资源。这些计划 所有人都被一个覆盖广泛受众的教育计划团结在一起：从本科生到 职业生涯中期的教职员工，从基础科学家到人口研究人员，从工作人员到社区成员。两者都有 可提供加速选项和强化计划。最后，一个强有力的试点计划将支付高达 每年800万美元的试点资金，重点是促进翻译和跨学科研究。

The University of Michigan Clinical and Translational Sciences Award (UM CTSA) will focus the formidable strengths of one of the world's finest research institutions on supporting and facilitating clinical and translational "team science". The UM CTSA will be housed in the newly created Michigan Institute of Clinical and Health Research (MICHR). MICHR was created by the University to maximize the potential of an institution that is extremely supportive of interdisciplinary research and has tremendous strengths in the health sciences. MICHR creates a partnership between relevant unit of the University, the NIH, external industry partners, and the community. The overwhelming majority of UM schools, colleges, and institutes are participating, including the top-ranked Schools of Business, Dentistry, Medicine, Nursing, Social Work, and Public Health, the Colleges of Engineering, Pharmacy, and Literature, Science and Arts, the Division of Kinesiology, the Institute of Social Research, and the Life Sciences Institute. The University-owned Health System, which includes integrated outpatient and inpatient facilities, is contributing significantly to a strong partnership with the UM CTSA. The Director of MICHR is the PI of the UM CTSA grant, and reports to a University Executive Vice President, who also oversees the Medical School and Health System. In addition to the grant resources, the institution is contributing nearly $11 million/vr of in-kind support, cost-sharing, support of pilot and recruitment programs, and renovation costs, a more than 1:1 match of NIH dollars. Blue Cross Blue Shield of Michigan and Pfizer are also making sizable investments. Departments are also contributing more than 100 FTE in potential faculty effort, so that MICHR can grant effort for pilot studies, K- 12, and new "mini-K programs". These aggregate resources are used to create robust infrastructure and support based on strong existing units and programs, as well as academic programs in key clinical and translational disciplines, to provide faculty leadership, expertise, and consultation as well as high quality services. These Programs are in Biomedical Informatics, Biostatistics, Clinical Translation, Novel Methods, Technical Cores, Community Engagement, Ethics, Health Disparities, Pediatrics, and Regulatory Support. A radically reconfigured Participant and Clinical Interactions Resource is also described. These programs are all united by an Education Program that reaches a wide spectrum of audiences: from undergraduates to mid-career faculty, from basic scientists to population researchers, from staff to community members. Both accelerated options and intensive programs are available. Finally, a robust pilot program will disburse up to $8 million/yr in pilot funds, focusing on stimulating translationaland interdisciplinary studies.